A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections
Abstract
Abstract Acinetobacter baumannii causes prolonged infections that disproportionately affect immunocompromised populations. Our understanding of A. baumannii respiratory pathogenesis relies on an acute murine infection model with limited clinical relevance that employs an unnaturally high number of bacteria and requires assessment of bacterial load at 24-36 h post-infection. Here, we demonstrate that low intranasal inoculums in tlr4 mutant mice allows for infections lasting at least 3 weeks. Using this “chronic infection model” we determine the adhesin InvL is a virulence factor required during later stages of infection, despite being dispensable in the early phase. We also demonstrate that the chronic model enables distinction between antibiotics that, although initially reduce bacterial burden, either lead to clearance or result in the formation of potential bacterial persisters. To illustrate how our model can be applied to study polymicrobial infections, we inoculate mice with an active A. baumannii infection with Staphylococcus aureus or Klebsiella pneumoniae. We find that S. aureus exacerbates infection, while K. pneumoniae enhances A. baumannii clearance. In all, the chronic model overcomes some limitations of the acute pulmonary model, expanding our capabilities to study A. baumannii pathogenesis and lays the groundwork for the development of similar models for other opportunistic pathogens.
Article Details
Authors (9)
Clay D. Jackson-Litteken
Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis
Gisela Di Venanzio
Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis
Manon Janet-Maitre
Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis
Ítalo A. Castro
Joseph J. Mackel
Leslie D. Wilson
David A. Rosen
Department of Pediatrics, Washington University School of Medicine, St. Louis
Carolina B. López
Mario F. Feldman
Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis